ccx-140
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2010 (NCT01028963)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- C-C chemokine receptor type 2ANTAGONIST
CCR2 antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS380F68J5PH ↗
- ChEMBLCHEMBL3545286 ↗
Also known as
- ccx140
- ccx140
- ccx-140
- ccx140-b
- ccx140-b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03703908 | Phase 2 | Oct 1, 2018 | ChemoCentryx |
| NCT03536754 | Phase 2 | May 1, 2018 | ChemoCentryx, Medpace, Inc. |
| NCT01447147 | Phase 2 | Oct 1, 2011 | ChemoCentryx |
| NCT01440257 | Phase 2 | Sep 1, 2011 | ChemoCentryx |
| NCT01028963 | Phase 2 | Jan 1, 2010 | ChemoCentryx |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ChemoCentryx | For profit | 5 | 5 | 1 | 2010 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1